Anzeige
Mehr »
Login
Mittwoch, 19.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897518 ISIN: US62855J1043 Ticker-Symbol: MYD 
Tradegate
18.02.20
19:09 Uhr
18,000 Euro
-0,100
-0,55 %
1-Jahres-Chart
MYRIAD GENETICS INC Chart 1 Jahr
5-Tage-Chart
MYRIAD GENETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
18,200
18,300
12:05
18,200
18,300
09:31

Aktuelle News zur MYRIAD GENETICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoMyriad Genetics (MYGN) Releases Favorable Prolaris Results9
MYRIAD GENETICS Aktie jetzt für 4€ handeln
FrMyriad Genetics, Inc.: New Study Demonstrates the Ability of Prolaris to Predict Which Men With Prostate Cancer Will Benefit from Multi-Modality Therapy2
DoMyriad Genetics (MYGN) Files for myChoice CDx Test sPMA4
11.02.Myriad Genetics, Inc.: Myriad Submits sPMA for myChoice CDx with Lynparza in First-Line Maintenance Therapy in Advanced Ovarian Cancer10
07.02.MYRIAD GENETICS INC - S-8, Securities to be offered to employees in employee benefit plans9
07.02.Myriad Genetics CEO Mark Capone Resigns17
07.02.Why Myriad Genetics Shares Are Tanking Today15
07.02.Stock Alert: Myriad Genetics Stock Down 30%701WASHINGTON (dpa-AFX) - Shares of Myriad Genetics Inc. (MYGN) are losing 30% to a 52-week low on Friday morning. The molecular diagnostic company on Thursday reported second-quarter results...
► Artikel lesen
07.02.Myriad Genetics (MYGN) Misses Q2 Earnings & Revenue Estimates24
07.02.HotStocks USA: -29% bei ZOGENIX, -28% bei MYRIAD GENETICS18
07.02.Myriad Genetics slips 27% premarket after weak FQ2 and guidance cut13
07.02.Myriad Genetics, Inc. (MYGN) CEO Bryan Riggsbee on Q2 2020 Results - Earnings Call Transcript13
07.02.Myriad Genetics, Inc. 2020 Q2 - Results - Earnings Call Presentation16
06.02.Myriad Genetics Q2 Results Miss Street, Outlook Weak; Shares Tank 29%286WASHINGTON (dpa-AFX) - Shares of Myriad Genetics Inc. (MYGN) plunged 29% in extended trading session on Thursday after the company reported a second-quarter profit and revenues that fell short...
► Artikel lesen
06.02.Myriad Genetics Shares Drop as CEO Resigns, Sales Fall Short5
06.02.Myriad Genetics Inc. Q2 adjusted earnings Miss Estimates240WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics Inc. (MYGN):-Earnings: -$8.3 million in Q2 vs. $2.6 million in the same period last year. -EPS: -$0.11 in Q2...
► Artikel lesen
06.02.MYRIAD GENETICS INC - 8-K, Current Report1
30.01.Myriad Genetics, Inc.: Myriad to Announce Fiscal Second-Quarter 2020 Financial Results on February 6, 20203
23.01.Myriad Genetics, Inc.: Myriad Submits sPMA for myChoice CDx with Zejula in First-Line Platinum Responsive Advanced Ovarian Cancer6
21.01.Myriad Genetics, Inc.: Myriad Submits sPMA for BRACAnalysis CDx as a Companion Diagnostic for Lynparza in Metastatic Castration-resistant Prostate Cancer-
Seite:  Weiter >>
73 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1